Literature DB >> 17050264

Olfactory functions in asymptomatic carriers of the Huntington disease mutation.

Maria Larsson1, Anders Lundin, Tarja-Brita Robins Wahlin.   

Abstract

Huntington's disease (HD) is a neurodegenerative disorder initially affecting the basal ganglia and especially the head of the caudate nucleus. Neuropsychological research has indicated that olfactory dysfunction may appear early in HD, prior to the onset of significant motor or cognitive dysfunction. The aim of this study was to examine whether asymptomatic carriers of the Huntington disease mutation also exhibit olfactory dysfunction. To address this issue we presented an extensive olfactory test battery comprising tasks assessing olfactory sensitivity, intensity discrimination, quality discrimination, episodic odor memory, and odor identification, to a group of gene carriers and nonmutation carriers of the disease. The results showed that gene carriers were selectively impaired in discriminating odor quality, although performance did not differ from noncarriers across the other tasks. The role played by striatum and then in particular the caudate nucleus for olfactory processing in general, and for odor quality discrimination in particular, is discussed.

Entities:  

Mesh:

Year:  2006        PMID: 17050264     DOI: 10.1080/13803390500473746

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  11 in total

1.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

2.  The effects of chronic alcoholism on cell proliferation in the human brain.

Authors:  G T Sutherland; P J Sheahan; J Matthews; C V P Dennis; D S Sheedy; T McCrossin; M A Curtis; J J Kril
Journal:  Exp Neurol       Date:  2013-03-28       Impact factor: 5.330

3.  [Olfactory dysfunction in neurodegenerative disorders].

Authors:  A Hähner; A Welge-Lüssen
Journal:  HNO       Date:  2010-07       Impact factor: 1.284

4.  Comparison of clinical tests of olfactory function.

Authors:  J Reden; C Draf; R A Frank; T Hummel
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-07       Impact factor: 2.503

Review 5.  Olfactory dysfunction: common in later life and early warning of neurodegenerative disease.

Authors:  Karl-Bernd Hüttenbrink; Thomas Hummel; Daniela Berg; Thomas Gasser; Antje Hähner
Journal:  Dtsch Arztebl Int       Date:  2013-01-07       Impact factor: 5.594

6.  The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.

Authors:  Nolwen L Rey; Daniel W Wesson; Patrik Brundin
Journal:  Neurobiol Dis       Date:  2016-12-20       Impact factor: 5.996

7.  Motor decline in clinically presymptomatic spinocerebellar ataxia type 2 gene carriers.

Authors:  Luis Velázquez-Perez; Rosalinda Díaz; Ruth Pérez-González; Nalia Canales; Roberto Rodríguez-Labrada; Jacquelín Medrano; Gilberto Sánchez; Luis Almaguer-Mederos; Cira Torres; Juan Fernandez-Ruiz
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

8.  A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in mice.

Authors:  Sabine M Hölter; Mary Stromberg; Marina Kovalenko; Lillian Garrett; Lisa Glasl; Edith Lopez; Jolene Guide; Alexander Götz; Wolfgang Hans; Lore Becker; Birgit Rathkolb; Jan Rozman; Anja Schrewed; Martin Klingenspor; Thomas Klopstock; Holger Schulz; Eckhard Wolf; Wolfgang Wursta; Tammy Gillis; Hiroko Wakimoto; Jonathan Seidman; Marcy E MacDonald; Susan Cotman; Valérie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Jong-Min Lee; Vanessa C Wheeler
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

9.  Studies on the Q175 Knock-in Model of Huntington's Disease Using Functional Imaging in Awake Mice: Evidence of Olfactory Dysfunction.

Authors:  Craig F Ferris; Praveen Kulkarni; Steven Toddes; Jason Yee; William Kenkel; Mark Nedelman
Journal:  Front Neurol       Date:  2014-06-30       Impact factor: 4.003

Review 10.  Loss of Olfactory Function-Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders.

Authors:  Heike Rebholz; Ralf J Braun; Dennis Ladage; Wolfgang Knoll; Christoph Kleber; Achim W Hassel
Journal:  Front Neurol       Date:  2020-10-26       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.